Skye Bioscience, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
5AM Partners II, a significant shareholder in Skye Bioscience, Inc., has adopted a new 10b5-1 plan to sell up to 1.51 million shares of common stock between January and November 2026.